The incorporation of genomic selection into selective breeding programs has furthered prospects of genetic gain within the aquaculture industry. However, the optimisation of commercial traits through selective breeding can be a lengthy process, especially when a target trait is influenced by numerous loci , epigenetics or exhibits low heritability. In Australia, barramundi (Lates calcarifer ) is an iconic fish that is often regarded for its versatility, light flavour, as well as high nutritional value. Despite optimal farming conditions and balanced nutrition, Australian farmed barramundi tend to exhibit “greying” of the fillet flesh, which tends to lower consumer acceptance when compared to other white flesh fish. Rare, “golden coloured skin” barramundi do not exhibit this fillet greyness; therefore, industry is looking to farm this colour variant.
Unfortunately, it is currently impossible to produce commercial numbers of golden barramundi due to a lack of genetic penetrance of the trait. Since the greyness of the fillet appears to be associated with the presence of melanin, this study used CRISPR/Cas9 gene editing to knockout genes within the melanogenesis pathway to achieve hypopigmentation. Sequencing of target regions revealed that approximately half of the larval fish that had been injected with CRISPR/Cas9 at the embryonic stage were determined to have indel formation (Figure 1) . Those with the highest mutation rates also had a significant observable reduction in pigmentation (Figure 2, p < 0.05) and lower gene expression for one of the genes (p < 0.01) . Overall, this study marks the first successful instance of gene editing to target pigmentation in barramundi , offers important insights into the melanogenesis pathway , and lays the groundwork for breeding of gene-edited fish for further phenotypic analyses of fillet quality in the future.